Valneva SE (VALN) Cash & Equivalents (2019 - 2026)

Valneva SE (VALN) posted quarterly Cash & Equivalents of $119.8 million for Q1 2026, down 31.19% year-on-year from $174.1 million in Q1 2025, and down 4.0% on a QoQ basis from $124.8 million in Q4 2025.

Valneva SE (VALN) Cash & Equivalents (2019 - 2026) Analysis & Trends

Valneva SE (VALN) has reported Cash & Equivalents for 8 consecutive years, with $119.8 million the latest figure, recorded in Q1 2026.

  • Quarterly Cash & Equivalents fell 31.19% year-over-year to $119.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $119.8 million (down 31.19% YoY) and the FY2025 annual result came in at $124.8 million, down 34.84% from the prior year.
  • Cash & Equivalents eased to $119.8 million in Q1 2026 per VALN's latest filing, from $124.8 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for VALN reached as high as $382.6 million in Q2 2022 and fell as low as $119.8 million in Q1 2026.
  • A 5-year average of $218.0 million and a median of $191.5 million in 2024 frame the typical range for Cash & Equivalents.
  • Annual changes were most pronounced in 2022 — Cash & Equivalents jumped 716230.0% — and 2023, when it slumped 56.0%.
  • Year by year, Cash & Equivalents stood at $326.1 million in 2022, then sank by 56.0% to $143.5 million in 2023, then soared by 33.46% to $191.5 million in 2024, then plunged by 34.84% to $124.8 million in 2025, then dropped by 4.0% to $119.8 million in 2026.
  • According to Business Quant data, Cash & Equivalents over the past three periods registered $119.8 million, $124.8 million, and $163.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 82.45 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 61.40 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 4.79 Bn
4 NuCana 279.75 Bn 279.75 Bn - 32.26 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 5.49 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 2.96 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 3.58 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 440.94 Mn
10 Valneva SE 803.90 Mn 680.66 Mn 5.38 Mn 119.79 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 119.79 Mn
Dec 31, 2025 124.78 Mn
Sep 30, 2025 163.25 Mn
Jun 30, 2025 183.56 Mn
Mar 31, 2025 174.10 Mn
Dec 31, 2024 191.48 Mn
Sep 30, 2024 177.90 Mn
Jun 30, 2024 149.54 Mn
Mar 31, 2024 201.01 Mn
Dec 31, 2023 143.47 Mn
Sep 30, 2023 194.88 Mn
Jun 30, 2023 232.61 Mn
Mar 31, 2023 289.59 Mn
Dec 31, 2022 326.06 Mn
Sep 30, 2022 297.05 Mn
Jun 30, 2022 382.61 Mn
Mar 31, 2022 354.20 Mn
Dec 31, 2021 45,518.17
Sep 30, 2021 282.15 Mn
Jun 30, 2021 375.30 Mn